# The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma

> **NCT00459069** · PHASE1 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 18 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** Dendritic Cell Tumor Fusion Vaccine

## Key facts

- **NCT ID:** NCT00459069
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-06
- **Final completion:** 2009-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2010-01-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00459069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00459069, "The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00459069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*